Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 27002 | 27.1 |
09:34 ET | 900 | 27.07 |
09:36 ET | 3060 | 27.15 |
09:38 ET | 1799 | 27.15 |
09:39 ET | 5324 | 27.17 |
09:41 ET | 7072 | 27.16 |
09:43 ET | 3585 | 27.12 |
09:45 ET | 5947 | 27.06 |
09:48 ET | 14881 | 26.95 |
09:50 ET | 2850 | 26.94 |
09:52 ET | 3007 | 27.01 |
09:54 ET | 2323 | 27.01 |
09:56 ET | 1500 | 27.02 |
09:57 ET | 2396 | 27 |
09:59 ET | 8730 | 27.01 |
10:01 ET | 5167 | 27.01 |
10:03 ET | 2178 | 26.99 |
10:06 ET | 3956 | 26.995 |
10:08 ET | 2376 | 26.9999 |
10:10 ET | 1125 | 27.005 |
10:12 ET | 2888 | 27.05 |
10:14 ET | 1955 | 27.0299 |
10:15 ET | 1441 | 27.025 |
10:17 ET | 2800 | 27.065 |
10:19 ET | 4355 | 27.1001 |
10:21 ET | 400 | 27.105 |
10:24 ET | 1820 | 27.1 |
10:26 ET | 500 | 27.085 |
10:28 ET | 7231 | 27.06 |
10:30 ET | 2060 | 27.06 |
10:32 ET | 2037 | 27.02 |
10:33 ET | 3400 | 27.01 |
10:35 ET | 12030 | 27.035 |
10:37 ET | 4398 | 27.035 |
10:39 ET | 6243 | 27.06 |
10:42 ET | 3000 | 27.045 |
10:44 ET | 3314 | 27 |
10:46 ET | 3865 | 27 |
10:48 ET | 5502 | 27.02 |
10:50 ET | 600 | 27.005 |
10:51 ET | 2075 | 27.005 |
10:53 ET | 3411 | 27.015 |
10:55 ET | 1800 | 27.009 |
10:57 ET | 2352 | 27.025 |
11:00 ET | 1360 | 27.035 |
11:02 ET | 2100 | 27.03 |
11:04 ET | 3800 | 27.02 |
11:06 ET | 2100 | 27.055 |
11:08 ET | 5329 | 27.065 |
11:09 ET | 7152 | 27.085 |
11:11 ET | 5077 | 27.09 |
11:13 ET | 4636 | 27.065 |
11:15 ET | 3601 | 27.1006 |
11:18 ET | 3658 | 27.135 |
11:20 ET | 500 | 27.145 |
11:22 ET | 6261 | 27.13 |
11:24 ET | 3145 | 27.125 |
11:26 ET | 900 | 27.145 |
11:27 ET | 1600 | 27.155 |
11:29 ET | 1655 | 27.16 |
11:31 ET | 5997 | 27.145 |
11:33 ET | 890 | 27.155 |
11:36 ET | 2340 | 27.155 |
11:38 ET | 4686 | 27.16 |
11:40 ET | 2986 | 27.16 |
11:42 ET | 4445 | 27.175 |
11:44 ET | 3480 | 27.18 |
11:45 ET | 1600 | 27.15 |
11:47 ET | 1253 | 27.165 |
11:49 ET | 505 | 27.165 |
11:51 ET | 500 | 27.165 |
11:54 ET | 16004 | 27.2 |
11:56 ET | 1886 | 27.185 |
11:58 ET | 1444 | 27.18 |
12:00 ET | 1976 | 27.195 |
12:02 ET | 2166 | 27.185 |
12:03 ET | 4629 | 27.18 |
12:05 ET | 2923 | 27.18 |
12:07 ET | 2200 | 27.18 |
12:09 ET | 595 | 27.185 |
12:12 ET | 600 | 27.185 |
12:14 ET | 3511 | 27.19 |
12:16 ET | 700 | 27.19 |
12:18 ET | 5067 | 27.195 |
12:20 ET | 7726 | 27.2 |
12:21 ET | 3922 | 27.225 |
12:23 ET | 4394 | 27.22 |
12:25 ET | 562 | 27.225 |
12:27 ET | 22540 | 27.235 |
12:30 ET | 6861 | 27.225 |
12:32 ET | 2140 | 27.235 |
12:34 ET | 622 | 27.235 |
12:36 ET | 1000 | 27.235 |
12:38 ET | 826 | 27.235 |
12:39 ET | 4840 | 27.265 |
12:41 ET | 6796 | 27.255 |
12:43 ET | 7718 | 27.265 |
12:45 ET | 3450 | 27.275 |
12:48 ET | 7773 | 27.265 |
12:50 ET | 1699 | 27.27 |
12:52 ET | 4499 | 27.27 |
12:54 ET | 1741 | 27.275 |
12:56 ET | 2816 | 27.26 |
12:57 ET | 400 | 27.265 |
12:59 ET | 4300 | 27.265 |
01:01 ET | 7930 | 27.25 |
01:03 ET | 1563 | 27.265 |
01:06 ET | 5674 | 27.3 |
01:08 ET | 2000 | 27.305 |
01:10 ET | 1283 | 27.3099 |
01:12 ET | 5599 | 27.32 |
01:14 ET | 7995 | 27.32 |
01:15 ET | 636 | 27.32 |
01:17 ET | 6647 | 27.325 |
01:19 ET | 3101 | 27.32 |
01:21 ET | 100 | 27.325 |
01:24 ET | 5794 | 27.32 |
01:26 ET | 1134 | 27.32 |
01:28 ET | 1200 | 27.325 |
01:30 ET | 1298 | 27.325 |
01:32 ET | 5389 | 27.33 |
01:33 ET | 11879 | 27.33 |
01:35 ET | 5189 | 27.305 |
01:37 ET | 1894 | 27.305 |
01:39 ET | 2543 | 27.3 |
01:42 ET | 2100 | 27.315 |
01:44 ET | 1911 | 27.315 |
01:46 ET | 8068 | 27.315 |
01:48 ET | 9929 | 27.315 |
01:50 ET | 6053 | 27.31 |
01:51 ET | 11937 | 27.28 |
01:53 ET | 400 | 27.285 |
01:55 ET | 2461 | 27.295 |
01:57 ET | 200 | 27.295 |
02:00 ET | 3500 | 27.295 |
02:02 ET | 9687 | 27.29 |
02:04 ET | 7400 | 27.27 |
02:06 ET | 3600 | 27.28 |
02:08 ET | 692 | 27.285 |
02:09 ET | 847 | 27.285 |
02:11 ET | 7790 | 27.295 |
02:13 ET | 2604 | 27.275 |
02:15 ET | 3330 | 27.275 |
02:18 ET | 7654 | 27.235 |
02:20 ET | 5254 | 27.24 |
02:22 ET | 2748 | 27.235 |
02:24 ET | 1800 | 27.2353 |
02:26 ET | 7883 | 27.23 |
02:27 ET | 4205 | 27.23 |
02:29 ET | 2572 | 27.24 |
02:31 ET | 1799 | 27.235 |
02:33 ET | 756 | 27.235 |
02:36 ET | 2992 | 27.24 |
02:38 ET | 12577 | 27.21 |
02:40 ET | 100 | 27.215 |
02:42 ET | 2500 | 27.215 |
02:44 ET | 7367 | 27.21 |
02:45 ET | 3353 | 27.19 |
02:47 ET | 4697 | 27.175 |
02:49 ET | 900 | 27.175 |
02:51 ET | 13731 | 27.195 |
02:54 ET | 1600 | 27.205 |
02:56 ET | 400 | 27.21 |
02:58 ET | 1842 | 27.205 |
03:00 ET | 5900 | 27.205 |
03:02 ET | 13484 | 27.195 |
03:03 ET | 2171 | 27.19 |
03:05 ET | 5218 | 27.205 |
03:07 ET | 4333 | 27.205 |
03:09 ET | 14693 | 27.21 |
03:12 ET | 6555 | 27.205 |
03:14 ET | 3363 | 27.21 |
03:16 ET | 5739 | 27.1808 |
03:18 ET | 2113 | 27.195 |
03:20 ET | 6867 | 27.205 |
03:21 ET | 1741 | 27.215 |
03:23 ET | 3796 | 27.225 |
03:25 ET | 1466 | 27.225 |
03:27 ET | 6614 | 27.21 |
03:30 ET | 5547 | 27.195 |
03:32 ET | 13946 | 27.15 |
03:34 ET | 3565 | 27.165 |
03:36 ET | 5302 | 27.155 |
03:38 ET | 3437 | 27.14 |
03:39 ET | 4308 | 27.155 |
03:41 ET | 10244 | 27.185 |
03:43 ET | 11416 | 27.16 |
03:45 ET | 2724 | 27.14 |
03:48 ET | 13061 | 27.18 |
03:50 ET | 7347 | 27.185 |
03:52 ET | 21662 | 27.195 |
03:54 ET | 18303 | 27.185 |
03:56 ET | 52227 | 27.24 |
03:57 ET | 17118 | 27.22 |
03:59 ET | 43193 | 27.2 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.3B | 15.3x | +1.83% |
Amneal Pharmaceuticals Inc | 2.2B | -12.4x | --- |
Catalent Inc | 10.1B | -8.6x | --- |
Jazz Pharmaceuticals PLC | 7.0B | 23.3x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.3B | 15.5x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.3B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.09% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.3x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 13.6x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.